229 related articles for article (PubMed ID: 33622897)
41. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
[TBL] [Abstract][Full Text] [Related]
43. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
44. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
45. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
Nygård M; Aagnes B; Bray F; Møller B; Mork J
Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
[TBL] [Abstract][Full Text] [Related]
46. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
[TBL] [Abstract][Full Text] [Related]
47. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
[TBL] [Abstract][Full Text] [Related]
48. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
[TBL] [Abstract][Full Text] [Related]
49. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
Hou Y; Chaudhary S; Shen R; Li Z
Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
[TBL] [Abstract][Full Text] [Related]
50. Prognostic impact of regulatory T cell in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Cho JH; Lim YC
Oral Oncol; 2021 Jan; 112():105084. PubMed ID: 33181417
[TBL] [Abstract][Full Text] [Related]
51. Impact of single nucleotide polymorphisms and cigarette smoking on cancer risk and survival of patients with head and neck squamous cell carcinoma.
Andersson BÅ; Nilsson M; Oliva D
Biomarkers; 2022 Nov; 27(7):694-700. PubMed ID: 35830713
[No Abstract] [Full Text] [Related]
52. Current Status of Human Papillomavirus-Targeted Therapies Development in Head and Neck Cancer.
Park JC; Bertaux B; Park J; Park S
JCO Precis Oncol; 2023 Jun; 7():e2300098. PubMed ID: 37315264
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
[TBL] [Abstract][Full Text] [Related]
54. The role of human papillomavirus infection in head and neck cancers.
Syrjänen S
Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
[TBL] [Abstract][Full Text] [Related]
55. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007).
Termine N; Panzarella V; Falaschini S; Russo A; Matranga D; Lo Muzio L; Campisi G
Ann Oncol; 2008 Oct; 19(10):1681-90. PubMed ID: 18558666
[TBL] [Abstract][Full Text] [Related]
56. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
57. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
Huho AN; Yadak N; Bocklage TJ; Yang S
J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
[TBL] [Abstract][Full Text] [Related]
59. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
